Skip to main content
Top
Published in: BMC Public Health 1/2012

Open Access 01-12-2012 | Research article

The impact of immigration and vaccination in reducing the incidence of hepatitis B in Catalonia (Spain)

Authors: Manuel Oviedo, M Pilar Muñoz, Gloria Carmona, Eva Borrás, Joan Batalla, Nuria Soldevila, Angela Domínguez

Published in: BMC Public Health | Issue 1/2012

Login to get access

Abstract

Background

The Hepatitis B virus (HBV) infection is a major cause of liver disease and liver cancer worldwide according to the World Health Organization. Following acute HBV infection, 1-5% of infected healthy adults and up to 90% of infected infants become chronic carriers and have an increased risk of cirrhosis and primary hepatocellular carcinoma. The aim of this study was to investigate the relationship between the reduction in acute hepatitis B incidence and the universal vaccination programme in preadolescents in Catalonia (Spain), taking population changes into account, and to construct a model to forecast the future incidence of cases that permits the best preventive strategy to be adopted.

Methods

Reported acute hepatitis B incidence in Catalonia according to age, gender, vaccination coverage, percentage of immigrants and the year of report of cases was analysed. A statistical analysis was made using three models: generalized linear models (GLM) with Poisson or negative binomial distribution and a generalized additive model (GAM).

Results

The higher the vaccination coverage, the lower the reported incidence of hepatitis B (p <0.01). In groups with vaccination coverage > 70%, the reduction in incidence was 2-fold higher than in groups with a coverage <70% (p <0.01). The increase in incidence was significantly-higher in groups with a high percentage of immigrants and more than 15% (p <0.01) in immigrant males of working age (19-49 years).

Conclusions

The results of the adjusted models in this study confirm that the global incidence of hepatitis B has declined in Catalonia after the introduction of the universal preadolescent vaccination programme, but the incidence increased in male immigrants of working age. Given the potential severity of hepatitis B for the health of individuals and for the community, universal vaccination programmes should continue and programmes in risk groups, especially immigrants, should be strengthened.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mackie CO, Buxton JA, Tadwalkar S, Patrick DM: Hepatitis B immunization strategies: timing is everything. Can Med J A. 2009, 20: 196-202.CrossRef Mackie CO, Buxton JA, Tadwalkar S, Patrick DM: Hepatitis B immunization strategies: timing is everything. Can Med J A. 2009, 20: 196-202.CrossRef
2.
go back to reference Zanetti A, Van Damme P, Shouval D: The global impact of vaccination against hepatitis B: A historical overview. Vaccine. 2008, 26: 6266-6273. 10.1016/j.vaccine.2008.09.056.CrossRefPubMed Zanetti A, Van Damme P, Shouval D: The global impact of vaccination against hepatitis B: A historical overview. Vaccine. 2008, 26: 6266-6273. 10.1016/j.vaccine.2008.09.056.CrossRefPubMed
3.
go back to reference Piorkowsky NY: Europe’s hepatitis challenge: defusing the “viral bomb”. J Hepatol. 2009, 5: 1068-1073.CrossRef Piorkowsky NY: Europe’s hepatitis challenge: defusing the “viral bomb”. J Hepatol. 2009, 5: 1068-1073.CrossRef
4.
go back to reference Levy AR, Kowdley KV, lloeje U, Taffese E, Mukherjee J, Gish R, Bzowej N, Briggs AH: The impact of chronic hepatitis B on quality of life: a multinational study of utilities from infected and uninfected persons. Value in Health. 2008, 11: 527-538. 10.1111/j.1524-4733.2007.00297.x.CrossRefPubMed Levy AR, Kowdley KV, lloeje U, Taffese E, Mukherjee J, Gish R, Bzowej N, Briggs AH: The impact of chronic hepatitis B on quality of life: a multinational study of utilities from infected and uninfected persons. Value in Health. 2008, 11: 527-538. 10.1111/j.1524-4733.2007.00297.x.CrossRefPubMed
5.
go back to reference Beutels P: Economic evaluations of hepatitis B immunization: a global review of recent studies (1994–2000). Heal Econ. 2001, 10: 751-774. 10.1002/hec.625.CrossRef Beutels P: Economic evaluations of hepatitis B immunization: a global review of recent studies (1994–2000). Heal Econ. 2001, 10: 751-774. 10.1002/hec.625.CrossRef
6.
go back to reference Weinbaum CM, Williams I, Mast EE, Wang SA, Finelli L, Wasley A, Neitzel M, Ward JW: Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR. 2008, 57 (RR08): 1-20.PubMed Weinbaum CM, Williams I, Mast EE, Wang SA, Finelli L, Wasley A, Neitzel M, Ward JW: Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR. 2008, 57 (RR08): 1-20.PubMed
7.
go back to reference World Health Organization: Viral hepatitis. Report by the Secretariat. Executive Board. 2009, Geneva: WHO World Health Organization: Viral hepatitis. Report by the Secretariat. Executive Board. 2009, Geneva: WHO
8.
go back to reference Salleras L, Bruguera JM, Vidal J, Taberner JL, Plans P, Bayas JM, Pumarola T, Jimenez de Anta MT, Rodés J: Prevalence of hepatitis B markers in the population of Catalonia (Spain) Rationale for universal vaccination of adolescents. Eur J Epidemiol. 1992, 8 (5): 640-644. 10.1007/BF00145377.CrossRefPubMed Salleras L, Bruguera JM, Vidal J, Taberner JL, Plans P, Bayas JM, Pumarola T, Jimenez de Anta MT, Rodés J: Prevalence of hepatitis B markers in the population of Catalonia (Spain) Rationale for universal vaccination of adolescents. Eur J Epidemiol. 1992, 8 (5): 640-644. 10.1007/BF00145377.CrossRefPubMed
9.
go back to reference Lopalco PL, Salleras L, Barbuti S, Germinario C, Bruguera M, Buti M, Domínguez A: Hepatitis A and B in children and adolescents – what can we learn from Puglia (Italy) and Catalonia (Spain). Vaccine. 2000, 19 (4-5): 470--474. 10.1016/S0264-410X(00)00193-6.CrossRefPubMed Lopalco PL, Salleras L, Barbuti S, Germinario C, Bruguera M, Buti M, Domínguez A: Hepatitis A and B in children and adolescents – what can we learn from Puglia (Italy) and Catalonia (Spain). Vaccine. 2000, 19 (4-5): 470--474. 10.1016/S0264-410X(00)00193-6.CrossRefPubMed
10.
go back to reference Salleras L, Dominguez A, Bruguera M, Cardeñosa N, Batalla J, Carmona G, Navas E, Taberner JL: Dramatic decline in acute hepatitis B infection and disease incidence rates among adolescents and young people after 12 years of a mass hepatitis B vaccination programme of pre-adolescents in the schools of Catalonia (Spain). Vaccine. 2005, 23: 2181-2184. 10.1016/j.vaccine.2005.01.068.CrossRefPubMed Salleras L, Dominguez A, Bruguera M, Cardeñosa N, Batalla J, Carmona G, Navas E, Taberner JL: Dramatic decline in acute hepatitis B infection and disease incidence rates among adolescents and young people after 12 years of a mass hepatitis B vaccination programme of pre-adolescents in the schools of Catalonia (Spain). Vaccine. 2005, 23: 2181-2184. 10.1016/j.vaccine.2005.01.068.CrossRefPubMed
11.
go back to reference Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS: A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol. 2005, 34: 1329-1339. 10.1093/ije/dyi206.CrossRefPubMed Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS: A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol. 2005, 34: 1329-1339. 10.1093/ije/dyi206.CrossRefPubMed
12.
go back to reference La Torre G, Nicolotti N, de Waure C, Chiaradia G, Specchia ML, Mannocci A, Ricciardi W: An assessment of the effect of hepatitis B vaccine in decreasing the amount of hepatitis B disease in Italy. Virol J. 2008, 5: 84-10.1186/1743-422X-5-84.CrossRefPubMedPubMedCentral La Torre G, Nicolotti N, de Waure C, Chiaradia G, Specchia ML, Mannocci A, Ricciardi W: An assessment of the effect of hepatitis B vaccine in decreasing the amount of hepatitis B disease in Italy. Virol J. 2008, 5: 84-10.1186/1743-422X-5-84.CrossRefPubMedPubMedCentral
13.
go back to reference Armstrong GL, Mast E, Wojczynski M, Margolis H: Childhood Hepatitis B Virus Infections in the United States Before Hepatitis B Immunization. Pediatrics. 2001, 108: 1123-1128. 10.1542/peds.108.5.1123.CrossRefPubMed Armstrong GL, Mast E, Wojczynski M, Margolis H: Childhood Hepatitis B Virus Infections in the United States Before Hepatitis B Immunization. Pediatrics. 2001, 108: 1123-1128. 10.1542/peds.108.5.1123.CrossRefPubMed
14.
go back to reference Thornley S, Bullen C, Roberts M: Hepatitis B in a high prevalence New Zealand population: a mathematical model applied to infection control policy. J Theor Biol. 2008, 254 (3): 599-603. 10.1016/j.jtbi.2008.06.022.CrossRefPubMed Thornley S, Bullen C, Roberts M: Hepatitis B in a high prevalence New Zealand population: a mathematical model applied to infection control policy. J Theor Biol. 2008, 254 (3): 599-603. 10.1016/j.jtbi.2008.06.022.CrossRefPubMed
16.
go back to reference Hastie TJ, Pregibon D: Generalized linear models. Chapter 6 of Statistical Models in S. Edited by: Chambers JM, Hastie TJ. 1992, Boca Raton, FL: Chapman&Hall/CRC, 195-248. Hastie TJ, Pregibon D: Generalized linear models. Chapter 6 of Statistical Models in S. Edited by: Chambers JM, Hastie TJ. 1992, Boca Raton, FL: Chapman&Hall/CRC, 195-248.
17.
go back to reference Venables WN, Ripley BD: Modern Applied Statistics with S. 2002, New York: SpringerCrossRef Venables WN, Ripley BD: Modern Applied Statistics with S. 2002, New York: SpringerCrossRef
18.
go back to reference Hastie TJ, Tibshirani RJ: Generalized additive models. 1990, New York: Chapman and Hill Hastie TJ, Tibshirani RJ: Generalized additive models. 1990, New York: Chapman and Hill
19.
go back to reference Oviedo M, Muñoz MP, Domínguez A, Borras E, Carmona G: A statistical model to estimate the impact of a hepatitis A vaccination programme. Vaccine. 2008, 26: 6157-6164. 10.1016/j.vaccine.2008.08.066.CrossRefPubMed Oviedo M, Muñoz MP, Domínguez A, Borras E, Carmona G: A statistical model to estimate the impact of a hepatitis A vaccination programme. Vaccine. 2008, 26: 6157-6164. 10.1016/j.vaccine.2008.08.066.CrossRefPubMed
20.
go back to reference Williamson JM, Lin HM, Lyles RH, Hightower AW: Power Calculations for ZIP and ZIPNB. J Data Sci. 2007, 5: 519-534. Williamson JM, Lin HM, Lyles RH, Hightower AW: Power Calculations for ZIP and ZIPNB. J Data Sci. 2007, 5: 519-534.
23.
go back to reference Raptopoulou M, Papatheodoridis G, Antoniou A, Ketikoglou J, Tzourmakliotis D, Vastiladis T, Manolaki N, Nikolopoulou G, Manesis E, Pierroutsakos I: Epidemiology, course and disease burden of chronic hepatitis B virus infection. HEPNET study for chronic hepatitis B: a multicentre Greek study. J Viral Hepat. 2009, 16: 195-202. 10.1111/j.1365-2893.2008.01057.x.CrossRefPubMed Raptopoulou M, Papatheodoridis G, Antoniou A, Ketikoglou J, Tzourmakliotis D, Vastiladis T, Manolaki N, Nikolopoulou G, Manesis E, Pierroutsakos I: Epidemiology, course and disease burden of chronic hepatitis B virus infection. HEPNET study for chronic hepatitis B: a multicentre Greek study. J Viral Hepat. 2009, 16: 195-202. 10.1111/j.1365-2893.2008.01057.x.CrossRefPubMed
24.
go back to reference Buti M, Homs M, Rodriguez-Frias , Funalleras G, Jardí R, Sauleda S, Tabernero D, Schaper M, Esteban R: Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study. J Viral Hepat. 2011, 18: 434-442. 10.1111/j.1365-2893.2010.01324.x.CrossRefPubMed Buti M, Homs M, Rodriguez-Frias , Funalleras G, Jardí R, Sauleda S, Tabernero D, Schaper M, Esteban R: Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study. J Viral Hepat. 2011, 18: 434-442. 10.1111/j.1365-2893.2010.01324.x.CrossRefPubMed
26.
go back to reference Mast EE, Weunbaum EE, Fiore AE, Alter MJ, Bell BP, Finelly L, Rodewald LE, Douglas JM, Jansen RS, Ward JW: A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. MMWR. 2006, 55 (RR16): 1-25.PubMed Mast EE, Weunbaum EE, Fiore AE, Alter MJ, Bell BP, Finelly L, Rodewald LE, Douglas JM, Jansen RS, Ward JW: A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. MMWR. 2006, 55 (RR16): 1-25.PubMed
27.
go back to reference Centers for Disease Control and Prevention: Recommended adult immunization schedule- United States, 2010. MMWR. 2010, 59: 1-4. Centers for Disease Control and Prevention: Recommended adult immunization schedule- United States, 2010. MMWR. 2010, 59: 1-4.
28.
go back to reference American Academy of Pediatrics: 2009 Report of the Committee on Infectious Diseases. Edited by: Elk Grove. 2009, Village, IL: American Academy of Pediatrics, 337-356. 28 American Academy of Pediatrics: 2009 Report of the Committee on Infectious Diseases. Edited by: Elk Grove. 2009, Village, IL: American Academy of Pediatrics, 337-356. 28
30.
go back to reference Baldo V, Floreani A, Menegon T, Grella P, Paternoster DM, Trivello R: Hepatitis C virus, hepatitis B virus and human immunodeficiency virus infection in pregnant women in North-East Italy: A seroepidemiological study. Eur J Epidemiol. 2000, 16: 87-91. 10.1023/A:1007600532105.CrossRefPubMed Baldo V, Floreani A, Menegon T, Grella P, Paternoster DM, Trivello R: Hepatitis C virus, hepatitis B virus and human immunodeficiency virus infection in pregnant women in North-East Italy: A seroepidemiological study. Eur J Epidemiol. 2000, 16: 87-91. 10.1023/A:1007600532105.CrossRefPubMed
31.
go back to reference Perz JF, Elm JL, Fiore AE, Huggler JI, Kuhnert WL, Effler PV: Near elimination of hepatitis B virus infections among Hawaii elementary school children after universal infant hepatitis B vaccination. Pediatrics. 2006, 118: 1403-1408. 10.1542/peds.2006-0724.CrossRefPubMed Perz JF, Elm JL, Fiore AE, Huggler JI, Kuhnert WL, Effler PV: Near elimination of hepatitis B virus infections among Hawaii elementary school children after universal infant hepatitis B vaccination. Pediatrics. 2006, 118: 1403-1408. 10.1542/peds.2006-0724.CrossRefPubMed
32.
go back to reference Kretzschmar M, Mangen MJ, van de Laar M, de Wit A: Model based analysis of hepatitis B vaccination strategies in the Netherlands. Vaccine. 2009, 27: 1254-1260. 10.1016/j.vaccine.2008.12.009.CrossRefPubMed Kretzschmar M, Mangen MJ, van de Laar M, de Wit A: Model based analysis of hepatitis B vaccination strategies in the Netherlands. Vaccine. 2009, 27: 1254-1260. 10.1016/j.vaccine.2008.12.009.CrossRefPubMed
33.
go back to reference Oviedo M, Muñoz MP, Domínguez A, Carmona G, Batalla J, Borras E, Jansa JM: Evaluation of mass vaccination programmes: the experience of hepatitis A in Catalonia. Rev Esp Salud Pública. 2009, 83: 697-709. 10.1590/S1135-57272009000500011.CrossRefPubMed Oviedo M, Muñoz MP, Domínguez A, Carmona G, Batalla J, Borras E, Jansa JM: Evaluation of mass vaccination programmes: the experience of hepatitis A in Catalonia. Rev Esp Salud Pública. 2009, 83: 697-709. 10.1590/S1135-57272009000500011.CrossRefPubMed
34.
go back to reference Paerce J, Dorling D: Geographical inequalities in health in New Zealand, 1980–2001. Int J Epidemiol. 2006, 35: 597-603. 10.1093/ije/dyl013.CrossRef Paerce J, Dorling D: Geographical inequalities in health in New Zealand, 1980–2001. Int J Epidemiol. 2006, 35: 597-603. 10.1093/ije/dyl013.CrossRef
Metadata
Title
The impact of immigration and vaccination in reducing the incidence of hepatitis B in Catalonia (Spain)
Authors
Manuel Oviedo
M Pilar Muñoz
Gloria Carmona
Eva Borrás
Joan Batalla
Nuria Soldevila
Angela Domínguez
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2012
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-12-614

Other articles of this Issue 1/2012

BMC Public Health 1/2012 Go to the issue